INMED PHARMACEUTICALS INC. Workers' Compensation Liability, Current
INMED PHARMACEUTICALS INC. (INM) had Workers' Compensation Liability, Current of $236.69 thousand as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Notes › Accounts Payable and Accrued Liabilities, Current
us-gaap:WorkersCompensationLiabilityCurrent · last filed 2024-11-14
- 2024-09-30: Workers' Compensation Liability, Current $236.69K.
- 2024-06-30: Workers' Compensation Liability, Current $488.28K.
- 2023-12-31: Workers' Compensation Liability, Current $422.22K.
- 2023-06-30: Workers' Compensation Liability, Current $542.30K.
| Period end | Workers' Compensation Liability, Current |
|---|---|
| 2024-09-30 | $236.69K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $488.28K 10-Q · filed 2024-11-14 |
| 2023-12-31 | $422.22K 10-Q · filed 2024-02-13 |
| 2023-06-30 | $542.30K 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |